Petition for Review – Federal Circuit
In response to the VA’s final rule implementing the Appeals Modernization Act, MVA filed a Petition for Review in the United States Court of Appeals for the Federal Circuit pursuant to 38 U.S.C. § 502.
The petition challenges portions of the rule as:
- Arbitrary and capricious
- Ultra vires (beyond statutory authority)
- Inconsistent with the pro-veteran canon
- Contrary to congressional intent
The litigation seeks to ensure that veterans retain meaningful appellate rights and access to fair judicial review.
The Legal Framework: 38 U.S.C. § 502
Section 502 of Title 38 provides jurisdiction for judicial review of VA rulemaking. This authority allows affected parties to challenge regulations that conflict with governing statutes.
MVA’s litigation relies on this statutory review mechanism to hold the agency accountable when regulations:
- Limit procedural safeguards
- Restrict attorney representation beyond congressional intent
- Impose unauthorized evidentiary constraints
- Narrow statutory remedies available to veterans
Protecting Veterans’ Appellate Rights
The veterans’ benefits system was designed to be non-adversarial and paternalistic. Courts have consistently recognized that veterans’ statutes are to be liberally construed in favor of those who served.
When regulatory action conflicts with that framework, judicial review becomes necessary.
MVA’s appellate litigation efforts are focused on:
- Preserving veterans’ due process rights
- Ensuring lawful rule implementation
- Safeguarding access to meaningful judicial review
- Maintaining consistency with federal appellate standards
Litigation as Part of a Broader Reform Strategy
MVA’s appellate litigation work complements its legislative advocacy for broader VA appellate reform. While Congress enacts statutory change, courts ensure those statutes are faithfully implemented.
Effective reform requires both.
Veterans deserve a fair, lawful, and efficient appellate system.
Military-Veterans Advocacy® will continue to pursue judicial remedies when regulatory actions undermine that promise.


